Abstract: Disclosed is a curtain wall assembly used for building exteriors. The curtain wall system includes a first vertical mullion operable to attach to a first sill member and a second vertical mullion operable to interlock with the first vertical mullion. A mullion cap may be attached to a bottom surface of at least one of the vertical mullions. The mullion cap includes a substantially planar bottom plate having an upper surface, a lower surface, a front edge, and a back edge. The mullion cap further includes an attachment face located on the upper surface of the substantially planar bottom plate. The attachment face is operable to attach to the vertical mullion.

Abstract: Disclosed is a curtain wall assembly used for building exteriors. The curtain wall system includes a first vertical mullion operable to attach to a first sill member and a second vertical mullion operable to interlock with the first vertical mullion. A mullion cap may be attached to a bottom surface of at least one of the vertical mullions. The mullion cap includes a substantially planar bottom plate having an upper surface, a lower surface, a front edge, and a back edge. The mullion cap further includes an attachment face located on the upper surface of the substantially planar bottom plate. The attachment face is operable to attach to the vertical mullion.

Abstract: A method for preventing or treating high serum levels of cholesterol and lipids in a mammal, said method comprising orally administering an effective amount of natural lycopene to prevent or treat high serum levels of cholesterol or lipid to a mammal in need of such treatment. Also disclosed is an oral pharmaceutical composition in unit dosage form for oral administration for the prevention or treatment of high serum levels of cholesterol and/or lipids in a mammal, said composition comprising an effective amount of natural lycopene to prevent or treat high serum levels of cholesterol or lipid in a mammal and in a sufficient amount to achieve a level of serum cholesterol of less than 200 mg per deciliter over the course of treatment, and a pharmaceutically acceptable carrier therefor.

Abstract: Pharmaceutical compositions comprising natural tocotrienols and natural tocopherols are disclosed. Also disclosed is a method for preventing or treating the harmful effects of high serum cholesterol and/or lipid levels in a mammal, said method comprising orally administering approximately 100 mg to approximately 1000 mg of natural tocotrienols and approximately 100 mg to approximately 1000 mg of tocopherols to a mammal, including humans, in need of such prevention or treatment.

Abstract: The present invention provides an antioxidant carotenoid composition substantially free of lutein comprising lutein esters. This antioxidant composition may readily be formulated into products for administration to humans to provide protection from the harmful effects of free radicals. The invention also provides a method of preventing or inhibiting the harmful effects of free radicals by administering an effective amount of an antioxidant carotenoid composition substantially free of lutein comprising lutein esters.

Abstract: A method for preventing or treating high serum levels of cholesterol and lipids in a mammal, said method comprising orally administering an effective amount of natural lycopene to prevent or treat high serum levels of cholesterol or lipids to a mammal in need of such treatment. Also disclosed is an oral pharmaceutical composition in unit dosage form for oral administration for the prevention or treatment of high serum levels of cholesterol and/or lipids in a mammal, said composition comprising an effective amount of natural lycopene to prevent or treat high serum levels of cholesterol or lipids in a mammal and in a sufficient amount to achieve a level of serum cholesterol of less than 200 mg per deciliter over the course of treatment, and a pharmaceutically acceptable carrier therefor.

Abstract: A mullion connection system includes a non-rectangular shear block which is formed by making angled, parallel cuts in a section of extruded material.

Abstract: A method for protecting the body against oxidation of low density lipoproteins by the oral administration of a protective amount of a natural tocopherol and tocopherol acetate or tocopherol succinate.

Abstract: A dry, particulate, free-flowing form of Vitamin E (.alpha.-tocopherol) is provided which includes a potency stabilizer for the Vitamin E. The potency stabilizers are hydroxy acids or amino acids such as ascorbic acid, citric acid, methionine and cysteine.

Abstract: Fatty ethers are provided which are lower alkyl ethers cyano-substituted lower alkyl ethers, ester ethers or amide ethers of fatty alcohols substituted with at least one of the following substituents: formyl, methylol, or acryloxymethyl. The substituted fatty ethers are useful as monomers in a wide variety of polymer systems.

Abstract: Dicyanoethenyl fatty compounds are provided which can be derivatized in a variety of ways to form a variety of compounds and polymeric products.

Abstract: Acryloxymethyl fatty compounds are provided which are useful as monomers in the preparation of radiation curable coatings. The preferred compounds are acrylate or methacrylate esters of 9(10)-(hydroxymethyl)stearonitrile, 9(10)-(hydroxymethyl)-N,N-dimethylstearamide, methyl 9(10)-(hydroxymethyl)-stearate, N-acetyl-N-methyl 9(10)-(hydroxymethyl)-nonadecanamine, 9(10)-cyano-octadecanol, 9(10)-(carboxydimethylamino)octadecanol, 9(10)-(carboxymethyoxy)octadecanol and 9(10)-(N-acetyl-N-methyl-aminomethyl)octadecanol.

Abstract: The seed, in the form of K.sub.2 SO.sub.4, is fed into an MHD combustor, mechanically recovered, and recycled. Sulfur dioxide in the discharge of the MHD channel is recovered downstream by a fluidized bed of lime/limestone.

Abstract: The present invention describes the conversion of steroids having a 20-amino functionality to progesterone and other useful steroids.